Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

Dr. Patrick Soon-Shiong said of rising cancer rates and COVID "it's not a coincidence" regarding both the virus and the shots.

The team includes Annabelle Wirths Tihanyi, Astrid Egan, Coral MacIntyre, Noya Slater Cohen and Olivia Gutierrez and is ...

UC San Diego's Moores Cancer Center has received a $1 million donation from pharmaceutical giant Pfizer to support early ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on ...

Cancer research funded through the National Institutes of Health, the National Cancer Institute and the Department of Defense Congressionally Directed Medical Research Program (CDMRP) has been ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new awareness campaign for pneumococcal pneumonia vaccination. Toward the end ...

Pfizer and Arvinas have shared promising top-line results from a late-stage study of their investigational protein degrader vepdegestrant in a subset of breast cancer patients. The phase 3 VERITAC-2 ...

Pfizer (NYSE:PFE) and its partner Arvinas (NASDAQ:ARVN) for the experimental breast cancer drug vepdegestrant announced mixed initial results from a Phase 3 trial for the protein degrader on Tuesday.

Pfizer announced positive outcomes from the Phase 3 VERITAC-2 clinical trial, showing vepdegestrant's promise in treating advanced breast cancer, which could be a significant driver of the company ...

Vepdegestrant met the primary endpoint in ESR1-mutant breast cancer, significantly improving progression-free survival over fulvestrant. The trial did not achieve statistical significance for PFS ...